2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
19
Breast Neoplasms
16
Pain
9
Agnosia
8
Lung Neoplasms
6
Prostatic Neoplasms
5
Neoplasms
5
Stomach Neoplasms
4
Colorectal Neoplasms
4
Postoperative Complications
3
Colonic Neoplasms
3
Supratentorial Neoplasms
2
Meningioma
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Sleep Deprivation
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pain, Intractable
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Malignant Neoplasms of Male Genital Organs
1
Liver Neoplasms
1
Liver Diseases
1
Interventions
Bupivacaine
2
acetaminophen, codeine drug combination
1
Triiodothyronine
1
Tramadol
1
Thyroxine
1
Thyroidectomy
1
Ropivacaine
1
Remote Consultation
1
Negative-Pressure Wound Therapy
1
Ketorolac
1
Indocyanine Green
1
Hyaluronic Acid
1
Glucose
1
Epinephrine
1
Dexmedetomidine
1
Data Collection
1
Clinical Protocols
1
Capsules
1
Calcium Carbonate
1
Calcitriol
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Goiter
×
Ropivacaine
×
Clear all
NCT02112370
2017-08-04
REBT
Seoul National University Hospital
Phase 3
Completed
148 enrolled
17 charts